Strategic market research partner to the pharmaceutical and biotechnology
industries strengthens specialist expertise
BOSTON, Jan. 3 /PRNewswire/ -- Observant LLC has announced the appointment of two senior executives with a passion for research excellence and a commitment to client service. John Hartman, Ph.D., a social scientist and statistician, has joined the firm as Vice President. Dr. Hartman's research has focused on the mathematical analysis of cross-national healthcare data; and his programming work has emphasized how best to present the complex relationships he uncovers to his clients in intuitive visual forms that are business actionable. Advances in computational power and statistical methodology have dramatically changed the ways in which data are analyzed and displayed, but such methods cannot be applied in a rote, unthinking manner. As Dr Hartman notes, "Real gains can be made in the way we display the results of our quantitative analyses. Many of the current visual displays fail to show variations in the precision of our estimates or how a subset of respondents may possess very different attitudes from the larger sample." Dr. Hartman believes that it is important to bear in mind that it's the creative mixture of therapeutic category expertise and rigorous data analysis that yields business critical insights.
The company is also pleased to announce that Jennifer Potter, Ph.D., M.P.H., has joined the firm as a Director. A clinical psychologist, Dr. Potter joins the firm from Harvard Medical School where her clinical research specialties included pain, substance use disorders, and the design and conduct of clinical trials. She has been a market research consultant for several years, managing studies across a range of therapeutic categories. Dr. Potter strengthens the company's scientific expertise in understanding the business implications of clinical trial design choices. As clinical trial designs become increasingly complex, how these impact physician prescribing behaviors becomes even more critical. Dr. Potter also believes strongly that knowledge of health behavior and clinical behavior should be applied to market research. According to Dr. Potter, "While gauging a doctor's or patient's enthusiasm for a product is a good first step, applying psychological principles of behavior change to market research enhances our clients' ability to influence product uptake."
Observant LLC is a strategic market research partner to the pharmaceutical and biotechnology industries worldwide. The firm offers a full spectrum of research and consulting services including analytically sophisticated quantitative studies and best-in-class qualitative research studies. Observant LLC supports its clients by conducting research in North America, Europe, Asia, South America, and Australia. Observant LLC principals and personnel have cross-industry backgrounds in consulting and public health and have published extensively on research methods and health science. For more information about the company, or to contact Dr. Hartman or Dr. Potter, please visit: http://www.observant.biz.
|SOURCE Observant LLC|
Copyright©2008 PR Newswire.
All rights reserved